Skip to content

Opening book details…

About this Medicine article

A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium by Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi, Katrina MacAlpine, Lisa Wang, John J. Wright, Amit M. Oza is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi, Katrina MacAlpine, Lisa Wang, John J. Wright, Amit M. Oza
Publisher
Springer US; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 0167-6997)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi, Katrina MacAlpine, Lisa Wang, John J. Wright, Amit M. Oza

Browse all works by Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi, Katrina MacAlpine, Lisa Wang, John J. Wright, Amit M. Oza